Skip to content

Syph-Check Syphilis Antibody Point of Care (POC) Test

One-Step Syphilis Point of Care Test for Rapid Immunoassay Screening of Antibodies to Treponema Pallidum

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00732355
Acronym
SyphPoc
Enrollment
400
Registered
2008-08-12
Start date
2009-03-31
Completion date
2010-09-30
Last updated
2016-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Screening for Syphilis Infections

Keywords

syphilis

Brief summary

The study is designed to evaluate the performance of a rapid membrane test in a clinic or doctor's office setting to identify potential patients infected with syphilis and compare the results to currently licensed laboratory based tests.

Detailed description

The overall objectives of this study are to determine the performance characteristics of a candidate rapid point-of-care test (Syph-Check cassette format) for Treponema pallidum antibodies in serum, plasma and finger stick whole blood obtained from females and males attending sexually transmitted diseases (STD) clinics, family planning / reproductive health clinics, and physician's office; and to compare the performance of this new, rapid test to currently licensed laboratory based tests, the non-treponemal RPR and a Treponemal ELISA or TPPA test.

Interventions

DEVICESyph-Check POC

Rapid membrane test for syphilis antibodies

Sponsors

Healthcare Providers Direct, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Men and Women will be eligible who: 1. are 18 years of age or older; 2. Routine presumed uninfected for screening visit, or show symptomatic signs of infection or are asymptomatic but are suspected of infection, and either/or have other STD disease conditions and infections, will be identified. 3. Pregnant women in the first and third trimester

Exclusion criteria

* are under 18 years of age * unwillingness to give consent

Design outcomes

Primary

MeasureTime frame
Identify the sensitivity and specificity of the POC test versus accepted laboratory testsend of study

Secondary

MeasureTime frame
Percent positive agreement data will include supplemental test results identified by infection categories and treatment as possibleend of study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026